Erythema Nodosum Following Hepavax-Gene Hepatitis B Vaccine Inoculation

摘要

Erythema nodosum (EN), a cutaneous reaction with sudden onset, consists of inflammatory, tender, warm nodular lesions, usually located bilaterally on the anterior aspects of the lower extremities. The nodules have bright red color initially, however, they become livid red or purplish within a few days, and finally they exhibit a yellow or greenish appearance. The lesions show spontaneous regression within 3-6 weeks, without ulceration or scarring and recurrent episodes are uncommon. Usually acute episodes of erythema nodosum are associated with fever, malaise, arthralgia, headache, abdominal pain, vomiting, cough and diarrhea (1). EN is a cutaneous reactive process that may be triggered by a wide variety of possible stimuli such as infectious diseases, sarcoidosis, rheumatologic disorders, inflammatory bowel diseases, malignancies and medications (1).We report a 35 year-old, non-pregnant woman with chief complaint of fever, chills and skin lesions following first hepatitis B vaccine injection was hospitalized at a teaching hospital in Tehran, Iran in November 2005.Twenty-four hour after vaccine administration, skin lesions appeared. Lesions began as several warm, red tender nodules. EN is discussed in this case report. Case Report A 35 year-old, non-pregnant woman with chief complaint of fever, chills and skin lesions following first hepatitis B vaccine injection (Hepavax-Gene; manufactured by Green Cross Vaccine Corp; Korea) was hospitalized at a teaching hospital in Tehran, Iran in November 2005.Her symptoms started 4 days before admission, 8h after hepatitis B vaccine inoculation, and included fever and chills; body pain added after about 12h of injection. Twenty-four hour after vaccine administration, skin lesions appeared. Lesions began as several warm, red tender nodules, with poorly defined borders located bilaterally on the both legs and vary from 2-6 cm (Figure 1).